Healthpeak Properties, Inc.
DOC- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0000765880
In the last 90 days, Healthpeak Properties, Inc. insiders filed 0 open-market purchases and 1 sale; 768 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:06 AM ET
Revenue flow, Q3 FY2026
Where the revenue went in Q3 FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one quarter, newest first.
| Line item | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025† | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024† |
|---|---|---|---|---|---|---|---|---|
| Period end | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
| Filing | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Reported | Nov 2, 2026 | Aug 4, 2026 | May 5, 2026 | Feb 2, 2026 | Oct 23, 2025 | Jul 24, 2025 | Apr 24, 2025 | Feb 3, 2025 |
| Revenue | $820.9M | $771.6M | $753.0M | $719.4M† | $705.9M | $694.3M | $702.9M | $698.0M† |
| Cost of revenue | – | – | – | – | $291.9M | $276.2M | $273.1M | $277.0M† |
| Selling, general and administrative | $23.6M | $22.5M | $24.6M | $23.6M† | $19.9M | $20.8M | $26.1M | $23.9M† |
| Interest expense | $83.9M | $92.3M | $87.3M | $80.6M† | $76.8M | $75.1M | $72.7M | $70.5M† |
| Income tax | $1.29M | -$1.40M | $254.0K | $6.03M† | -$1.21M | $2.38M | $2.08M | -$14.0M† |
| Net income | $17.3M | $52.8M | $193.6M | $114.0M† | -$117.1M | $31.7M | $42.8M | $4.55M† |
| EPS, basic | $0.02 | $0.08 | $0.28 | – | $-0.17 | $0.05 | $0.06 | – |
| EPS, diluted | $0.02 | $0.08 | $0.28 | – | $-0.17 | $0.05 | $0.06 | – |
| Weighted shares, basic | 689.5M | 689.9M | 695.2M | – | 694.9M | 695.2M | 699.1M | – |
| Weighted shares, diluted | 689.5M | 689.9M | 695.2M | – | 694.9M | 695.2M | 699.1M | – |
| Margins and growth | ||||||||
| Net margin | 2.1% | 6.8% | 25.7% | 15.8% | -16.6% | 4.6% | 6.1% | 0.7% |
| Revenue growth, year over year | +16.3% | +11.1% | +7.1% | +3.1% | +0.8% | −0.2% | +15.9% | +26.1% |
| Net income growth, year over year | – | +66.8% | +352.1% | +2,406.4% | −236.4% | −78.3% | +541.5% | −93.6% |
Balance sheet
Each column is one quarter, newest first.
| Line item | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025† | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024† |
|---|---|---|---|---|---|---|---|---|
| Period end | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
| Filing | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Reported | Nov 2, 2026 | Aug 4, 2026 | May 5, 2026 | Feb 2, 2026 | Oct 23, 2025 | Jul 24, 2025 | Apr 24, 2025 | Feb 3, 2025 |
| Cash and equivalents | $514.3M | $1.63B | $1.17B | $467.5M | $91.0M | $89.4M | $70.6M | $119.8M |
| Goodwill | $68.5M | $68.5M | $68.5M | $68.5M | $68.5M | $68.5M | $68.5M | $68.5M |
| Intangible assets | $917.7M | $717.5M | $758.5M | $654.5M | $610.5M | $677.1M | $747.8M | $817.3M |
| Total assets | $22.4B | $21.7B | $21.6B | $20.3B | $19.6B | $19.8B | $19.8B | $19.9B |
| Long-term debt | $9.38B | $10.0B | $10.4B | $9.85B | $9.13B | $9.04B | $8.88B | $8.72B |
| Total liabilities | $11.6B | $12.2B | $12.6B | $12.0B | $11.3B | $11.2B | $11.0B | $10.9B |
| Shareholders' equity | $10.8B | $9.47B | $9.03B | $8.14B | $8.24B | $8.57B | $8.83B | $9.06B |
Cash flow statement
Each column is one quarter, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | Q3 FY2026† | Q2 FY2026† | Q1 FY2026 | Q4 FY2025† | Q3 FY2025† | Q2 FY2025† | Q1 FY2025 | Q4 FY2024† |
|---|---|---|---|---|---|---|---|---|
| Period end | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
| Filing | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Reported | Nov 2, 2026 | Aug 4, 2026 | May 5, 2026 | Feb 2, 2026 | Oct 23, 2025 | Jul 24, 2025 | Apr 24, 2025 | Feb 3, 2025 |
| Operating cash flow | $354.5M† | $361.1M† | $260.9M | $294.1M† | $315.0M† | $363.5M† | $279.4M | $283.5M† |
| Depreciation and amortization | $298.9M | $283.4M | $289.7M | $262.1M† | $262.3M | $265.9M | $268.5M | $274.5M† |
| Stock-based compensation | $4.86M† | $4.81M† | $4.50M | $4.00M† | $4.04M† | $1.74M† | $4.63M | $3.61M† |
| Dividends paid | $210.3M† | $210.3M† | $212.0M | $211.9M† | $211.9M† | $211.9M† | $213.5M | $209.8M† |
| Share buybacks | $99.0K† | $100.2M† | $1.37M | $87.0K† | $17.0K† | $72.1M† | $25.0M | $326.0K† |
| Investing cash flow | -$2.07B† | $132.6M† | -$638.6M | -$405.6M† | -$188.1M† | -$210.3M† | -$230.7M | -$233.8M† |
| Financing cash flow | $605.7M† | -$41.0M† | $1.11B | $489.5M† | -$130.4M† | -$128.6M† | -$94.4M | -$107.5M† |
| Net change in cash | -$1.11B† | $452.8M† | $728.2M | $378.0M† | -$3.55M† | $24.7M† | -$45.7M | -$57.7M† |
| Ratio | ||||||||
| Stock-based compensation, % of revenue | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.3% | 0.7% | 0.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 689.5M | −0.8% | SEC |
| Aug 3, 2026 | 689.5M | −0.8% | SEC |
| May 4, 2026 | 689.4M | −0.8% | SEC |
| Jan 30, 2026 | 695.0M | −0.6% | SEC |
| Oct 22, 2025 | 694.9M | −0.6% | SEC |
| Jul 23, 2025 | 694.9M | −0.6% | SEC |
| Apr 23, 2025 | 694.7M | −1.3% | SEC |
| Jan 31, 2025 | 699.6M | +27.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- Values marked † are derived: Q4 is the full year minus the first three quarters, single-quarter cash flows are year-to-date figures minus the previous year-to-date figures, and the Q4 balance sheet is the year-end balance sheet.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.